UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Wiendl, H; Bourdette, D; Ciccarelli, O; (2017) Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis? [Editorial comment]. Neurology , 89 (11) pp. 1098-1100. 10.1212/WNL.0000000000004381. Green open access

[thumbnail of Ciccarelli_1098.full.pdf]
Preview
 Text
Ciccarelli_1098.full.pdf - Published Version
Download (307kB) | Preview
Type: Article
Title: Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1212/WNL.0000000000004381
Publisher version: http://doi.org/10.1212/WNL.0000000000004381
Language: English
Additional information: This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation
URI: https://discovery.ucl.ac.uk/id/eprint/1573226
Downloads since deposit
175Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item